context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. </context> | us-gaap:EmployeeStockOwnershipPlanESOPDividendsPaidToESOP |
The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. </context> | us-gaap:EmployeeStockOwnershipPlanESOPDividendsPaidToESOP |
In the first quarter of 2023, the Company recorded a charge of $ 267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act seeking the recalculation of benefits and other relief associated with a 2005 residual annuity amendment to the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Retirement Plan”). The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. See Note 13, Commitments and Contingencies for additional information. | text | 267 | monetaryItemType | text: <entity> 267 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2023, the Company recorded a charge of $ 267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act seeking the recalculation of benefits and other relief associated with a 2005 residual annuity amendment to the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Retirement Plan”). The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. See Note 13, Commitments and Contingencies for additional information. </context> | us-gaap:LitigationSettlementExpense |
During the third quarter of 2022, the Company amended its domestic postretirement plan to limit eligibility for certain existing employees, eliminate eligibility for other existing employees and change the way coverage and subsidies are delivered for certain current and future retirees. As required, the Company remeasured the obligation for the domestic postretirement plan, which resulted in the reduction of the projected benefit obligation and a corresponding actuarial gain of $ 398 . The reduction of the projected benefit obligation and actuarial gain were primarily due to an increase in the discount rate since December 31, 2021 and the impact of the plan amendment. The actuarial gain was recorded in Accumulated other comprehensive income and will be amortized over future periods. | text | 398 | monetaryItemType | text: <entity> 398 </entity> <entity type> monetaryItemType </entity type> <context> During the third quarter of 2022, the Company amended its domestic postretirement plan to limit eligibility for certain existing employees, eliminate eligibility for other existing employees and change the way coverage and subsidies are delivered for certain current and future retirees. As required, the Company remeasured the obligation for the domestic postretirement plan, which resulted in the reduction of the projected benefit obligation and a corresponding actuarial gain of $ 398 . The reduction of the projected benefit obligation and actuarial gain were primarily due to an increase in the discount rate since December 31, 2021 and the impact of the plan amendment. The actuarial gain was recorded in Accumulated other comprehensive income and will be amortized over future periods. </context> | us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses |
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. | text | 6.00 | percentItemType | text: <entity> 6.00 </entity> <entity type> percentItemType </entity type> <context> The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. </context> | us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear |
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. | text | 4.50 | percentItemType | text: <entity> 4.50 </entity> <entity type> percentItemType </entity type> <context> The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. </context> | us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1 |
Other postretirement charges for the twelve months ended December 31, 2023 included pension and other charges of $ 5 incurred pursuant to the 2022 Global Productivity Initiative. The Company made no voluntary contributions in 2023, 2022, and 2021. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> Other postretirement charges for the twelve months ended December 31, 2023 included pension and other charges of $ 5 incurred pursuant to the 2022 Global Productivity Initiative. The Company made no voluntary contributions in 2023, 2022, and 2021. </context> | us-gaap:DefinedBenefitPlanOtherCosts |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. </context> | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 164 | monetaryItemType | text: <entity> 164 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. </context> | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 146 | monetaryItemType | text: <entity> 146 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. </context> | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
If all of the unrecognized tax benefits for 2023 above were recognized, approximately $ 304 would impact the effective tax rate. It is reasonably possible that the amount of unrecognized benefits with respect to our uncertain tax positions could change in the next twelve months and such change may or may not be material. | text | 304 | monetaryItemType | text: <entity> 304 </entity> <entity type> monetaryItemType </entity type> <context> If all of the unrecognized tax benefits for 2023 above were recognized, approximately $ 304 would impact the effective tax rate. It is reasonably possible that the amount of unrecognized benefits with respect to our uncertain tax positions could change in the next twelve months and such change may or may not be material. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. | text | 40 | monetaryItemType | text: <entity> 40 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
In the second quarter of 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of its subsidiaries and concluded that it is more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was not material to the Company in any year in which they were taken. The cumulative effect of the change in tax position of $ 148 was reflected as a discrete item in the second quarter’s income tax expense, partially offset by the reversal of certain prior years’ withholding tax reserves of $ 22 that are no longer required. The tax liability was paid in the quarter ended September 30, 2023. The current year impact of these changes is included in the Company’s full year effective income tax rate. | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of its subsidiaries and concluded that it is more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was not material to the Company in any year in which they were taken. The cumulative effect of the change in tax position of $ 148 was reflected as a discrete item in the second quarter’s income tax expense, partially offset by the reversal of certain prior years’ withholding tax reserves of $ 22 that are no longer required. The tax liability was paid in the quarter ended September 30, 2023. The current year impact of these changes is included in the Company’s full year effective income tax rate. </context> | us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions |
The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against unrelated third parties on similar matters. Despite the U.S. Tax Court rulings, the Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $ 145 , which is not included in the Company’s uncertain tax positions. | text | 145 | monetaryItemType | text: <entity> 145 </entity> <entity type> monetaryItemType </entity type> <context> The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against unrelated third parties on similar matters. Despite the U.S. Tax Court rulings, the Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $ 145 , which is not included in the Company’s uncertain tax positions. </context> | us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 13719286 | sharesItemType | text: <entity> 13719286 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 5236371 | sharesItemType | text: <entity> 5236371 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 2495393 | sharesItemType | text: <entity> 2495393 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 1183 | sharesItemType | text: <entity> 1183 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 155118 | sharesItemType | text: <entity> 155118 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. | text | 126378 | sharesItemType | text: <entity> 126378 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,183 , 155,118 and 126,378 , respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
As of December 31, 2023, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $ 757 . | text | 757 | monetaryItemType | text: <entity> 757 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $ 757 . </context> | us-gaap:LongTermPurchaseCommitmentAmount |
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. | text | 200 | integerItemType | text: <entity> 200 </entity> <entity type> integerItemType </entity type> <context> As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. </context> | us-gaap:NumberOfCountriesInWhichEntityOperates |
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $ 0 to approximately $ 300 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. | text | 0 | monetaryItemType | text: <entity> 0 </entity> <entity type> monetaryItemType </entity type> <context> The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $ 0 to approximately $ 300 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. </context> | us-gaap:LossContingencyEstimateOfPossibleLoss |
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $ 0 to approximately $ 300 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $ 0 to approximately $ 300 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. </context> | us-gaap:LossContingencyEstimateOfPossibleLoss |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. | text | 278 | integerItemType | text: <entity> 278 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. </context> | us-gaap:LossContingencyPendingClaimsNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. | text | 227 | integerItemType | text: <entity> 227 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. </context> | us-gaap:LossContingencyPendingClaimsNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. | text | 169 | integerItemType | text: <entity> 169 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. </context> | us-gaap:LossContingencyNewClaimsFiledNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. | text | 118 | integerItemType | text: <entity> 118 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2023, there were 278 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 227 cases as of December 31, 2022. During the year ended December 31, 2023, 169 new cases were filed and 118 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. </context> | us-gaap:LossContingencyClaimsSettledAndDismissedNumber |
In light of the Second Circuit decision, the Company recorded a charge to earnings of $ 267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated with this matter are expected to be immaterial and, where estimable, are reflected in the range of reasonably possible losses disclosed above. The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. In June 2023, the Company filed a petition for certiorari to the United States Supreme Court requesting permission for an appeal to that court and that petition was denied in October 2023. Also in June 2023, the plaintiffs filed a motion to enter a revised final judgment in the District Court to address certain unresolved calculation issues, which the Company opposed. | text | 267 | monetaryItemType | text: <entity> 267 </entity> <entity type> monetaryItemType </entity type> <context> In light of the Second Circuit decision, the Company recorded a charge to earnings of $ 267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated with this matter are expected to be immaterial and, where estimable, are reflected in the range of reasonably possible losses disclosed above. The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. In June 2023, the Company filed a petition for certiorari to the United States Supreme Court requesting permission for an appeal to that court and that petition was denied in October 2023. Also in June 2023, the plaintiffs filed a motion to enter a revised final judgment in the District Court to address certain unresolved calculation issues, which the Company opposed. </context> | us-gaap:LitigationSettlementExpense |
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. </context> | us-gaap:NumberOfOperatingSegments |
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11 %, 11 % and 12 % of the Company’s Net sales in 2023, 2022 and 2021, respectively. No other customer represented more than 10% of Net sales in any period presented. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11 %, 11 % and 12 % of the Company’s Net sales in 2023, 2022 and 2021, respectively. No other customer represented more than 10% of Net sales in any period presented. </context> | us-gaap:ConcentrationRiskPercentage1 |
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11 %, 11 % and 12 % of the Company’s Net sales in 2023, 2022 and 2021, respectively. No other customer represented more than 10% of Net sales in any period presented. | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11 %, 11 % and 12 % of the Company’s Net sales in 2023, 2022 and 2021, respectively. No other customer represented more than 10% of Net sales in any period presented. </context> | us-gaap:ConcentrationRiskPercentage1 |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. </context> | us-gaap:RestructuringCosts |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. </context> | us-gaap:RestructuringCosts |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. | text | 95 | monetaryItemType | text: <entity> 95 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. </context> | us-gaap:GainLossOnSaleOfProperties |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative of $ 95 , a gain on the sale of land in Asia Pacific of $ 47 and acquisition-related costs of $ 19 . In 2021, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 571 , and a benefit of $ 26 related to a value-added tax matter in Brazil. </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3625 | monetaryItemType | text: <entity> 3625 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3511 | monetaryItemType | text: <entity> 3511 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3391 | monetaryItemType | text: <entity> 3391 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2918 | monetaryItemType | text: <entity> 2918 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2432 | monetaryItemType | text: <entity> 2432 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2018 | monetaryItemType | text: <entity> 2018 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively | text | 171 | monetaryItemType | text: <entity> 171 </entity> <entity type> monetaryItemType </entity type> <context> Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively </context> | us-gaap:OperatingLeasePayments |
Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively | text | 169 | monetaryItemType | text: <entity> 169 </entity> <entity type> monetaryItemType </entity type> <context> Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively </context> | us-gaap:OperatingLeasePayments |
Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. | text | 139 | monetaryItemType | text: <entity> 139 </entity> <entity type> monetaryItemType </entity type> <context> Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. | text | 85 | monetaryItemType | text: <entity> 85 </entity> <entity type> monetaryItemType </entity type> <context> Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. | text | 4.5 | percentItemType | text: <entity> 4.5 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. | text | 3.9 | percentItemType | text: <entity> 3.9 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” | text | 471 | monetaryItemType | text: <entity> 471 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” </context> | us-gaap:LIFOInventoryAmount |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” | text | 458 | monetaryItemType | text: <entity> 458 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” </context> | us-gaap:LIFOInventoryAmount |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” | text | 120 | monetaryItemType | text: <entity> 120 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” </context> | us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” | text | 146 | monetaryItemType | text: <entity> 146 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory classified as non-current at December 31, 2023 was recorded on the Consolidated Balance Sheets as “Other assets.” </context> | us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. | text | 647 | monetaryItemType | text: <entity> 647 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. | text | 631 | monetaryItemType | text: <entity> 631 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. | text | 3351 | monetaryItemType | text: <entity> 3351 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. | text | 3491 | monetaryItemType | text: <entity> 3491 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $ 647 and $ 631 , respectively, and aftertax cumulative foreign currency translation adjustments of $ 3,351 and $ 3,491 , respectively. Foreign currency translation adjustments in 2023 primarily reflect gains from the Euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2022 primarily reflect losses from the Euro, Indian Rupee and Colombian Peso. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
As of the date of the company’s 2023 annual impairment test, the fair value of all reporting units exceeded their carrying values by more than 19 %. Discount rates are one of the more significant assumptions used in the income approach. If the company increased the discount rates used by 100 basis points, the fair value of all reporting units would still exceed their carrying values by more than 8 %. | text | 19 | percentItemType | text: <entity> 19 </entity> <entity type> percentItemType </entity type> <context> As of the date of the company’s 2023 annual impairment test, the fair value of all reporting units exceeded their carrying values by more than 19 %. Discount rates are one of the more significant assumptions used in the income approach. If the company increased the discount rates used by 100 basis points, the fair value of all reporting units would still exceed their carrying values by more than 8 %. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 568.2 | monetaryItemType | text: <entity> 568.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 110.0 | monetaryItemType | text: <entity> 110.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 783.6 | monetaryItemType | text: <entity> 783.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 391.7 | monetaryItemType | text: <entity> 391.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. | text | 197.0 | monetaryItemType | text: <entity> 197.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and EMEA reporting units within the global ECS reportable segment, respectively, and $ 197.0 million was allocated to the eInfochips reporting unit. Within the global components reportable segment, the Asia/Pacific reporting unit’s goodwill was previously fully impaired. Refer to Note 2. </context> | us-gaap:Goodwill |
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The company’s operations are classified into two reportable segments: global components and global ECS (see Note 16). | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The company’s operations are classified into two reportable segments: global components and global ECS (see Note 16). </context> | us-gaap:NumberOfReportableSegments |
No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of the company’s business, such as the company’s global ECS reportable segment, rely on a limited number of suppliers with the strategy of providing focused support, extensive product knowledge, and customized service to suppliers, value-added resellers (“VARs”), and managed service providers (“MSPs”). Most of the company’s purchases are pursuant to distributor agreements, which are typically non-exclusive and cancelable by either party at any time or on short notice. | text | 2 | percentItemType | text: <entity> 2 </entity> <entity type> percentItemType </entity type> <context> No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of the company’s business, such as the company’s global ECS reportable segment, rely on a limited number of suppliers with the strategy of providing focused support, extensive product knowledge, and customized service to suppliers, value-added resellers (“VARs”), and managed service providers (“MSPs”). Most of the company’s purchases are pursuant to distributor agreements, which are typically non-exclusive and cancelable by either party at any time or on short notice. </context> | us-gaap:ConcentrationRiskPercentage1 |
No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of the company’s business, such as the company’s global ECS reportable segment, rely on a limited number of suppliers with the strategy of providing focused support, extensive product knowledge, and customized service to suppliers, value-added resellers (“VARs”), and managed service providers (“MSPs”). Most of the company’s purchases are pursuant to distributor agreements, which are typically non-exclusive and cancelable by either party at any time or on short notice. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of the company’s business, such as the company’s global ECS reportable segment, rely on a limited number of suppliers with the strategy of providing focused support, extensive product knowledge, and customized service to suppliers, value-added resellers (“VARs”), and managed service providers (“MSPs”). Most of the company’s purchases are pursuant to distributor agreements, which are typically non-exclusive and cancelable by either party at any time or on short notice. </context> | us-gaap:ConcentrationRiskPercentage1 |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 31.2 | monetaryItemType | text: <entity> 31.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 34.7 | monetaryItemType | text: <entity> 34.7 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 36.9 | monetaryItemType | text: <entity> 36.9 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 29.5 | monetaryItemType | text: <entity> 29.5 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 20.3 | monetaryItemType | text: <entity> 20.3 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 19.5 | monetaryItemType | text: <entity> 19.5 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 18.9 | monetaryItemType | text: <entity> 18.9 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. | text | 11.2 | monetaryItemType | text: <entity> 11.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 million, $ 18.9 million, and $ 11.2 million, respectively. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive |
The company owns a 50 % interest in two joint ventures with Marubun Corporation (collectively “Marubun/Arrow”) and a 50 % interest in one other joint venture. These investments are accounted for using the equity method. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The company owns a 50 % interest in two joint ventures with Marubun Corporation (collectively “Marubun/Arrow”) and a 50 % interest in one other joint venture. These investments are accounted for using the equity method. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
The company monitors the current credit condition of its customers and other available information about expected credit losses in estimating its allowance for credit losses. During 2023, increases to the allowance for credit losses charged to income were $ 37.4 million higher than the prior year, primarily due to the aging of receivables of certain customers. With the exception of these few customers, as of December 31, 2023, the company has not experienced significant changes in customers’ payment trends or significant deterioration in customers’ credit risk. | text | 37.4 | monetaryItemType | text: <entity> 37.4 </entity> <entity type> monetaryItemType </entity type> <context> The company monitors the current credit condition of its customers and other available information about expected credit losses in estimating its allowance for credit losses. During 2023, increases to the allowance for credit losses charged to income were $ 37.4 million higher than the prior year, primarily due to the aging of receivables of certain customers. With the exception of these few customers, as of December 31, 2023, the company has not experienced significant changes in customers’ payment trends or significant deterioration in customers’ credit risk. </context> | us-gaap:FinancingReceivableAllowanceForCreditLossesRecovery |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | 500.0 | monetaryItemType | text: <entity> 500.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:LinesOfCreditCurrent |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | 78.0 | monetaryItemType | text: <entity> 78.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:LinesOfCreditCurrent |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | 5.83 | percentItemType | text: <entity> 5.83 </entity> <entity type> percentItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. | text | 5.22 | percentItemType | text: <entity> 5.22 </entity> <entity type> percentItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding borrowings under the uncommitted lines of credit at December 31, 2022. These borrowings were provided on a short-term basis and the maturity is agreed upon between the company and the lender. The uncommitted lines of credit had a weighted-average effective interest rate of 5.83 % and 5.22 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:CommercialPaper |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. | text | 173.4 | monetaryItemType | text: <entity> 173.4 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:CommercialPaper |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. | text | 5.90 | percentItemType | text: <entity> 5.90 </entity> <entity type> percentItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. | text | 5.15 | percentItemType | text: <entity> 5.15 </entity> <entity type> percentItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $ 1.1 billion in outstanding borrowings under the commercial paper program at December 31, 2023 and $ 173.4 million in outstanding borrowings under this program as of December 31, 2022. The commercial paper program had an effective interest rate of 5.90 % and 5.15 % at December 31, 2023 and 2022, respectively. </context> | us-gaap:ShortTermDebtWeightedAverageInterestRate |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 6.125 | percentItemType | text: <entity> 6.125 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 0.508 | percentItemType | text: <entity> 0.508 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. </context> | us-gaap:DerivativeVariableInterestRate |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 5.87 | percentItemType | text: <entity> 5.87 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. </context> | us-gaap:DebtInstrumentInterestRateEffectivePercentage |
The 7.50 % senior debentures are not redeemable prior to their maturity. All other notes may be called at the option of the company subject to “make whole” clauses. | text | 7.50 | percentItemType | text: <entity> 7.50 </entity> <entity type> percentItemType </entity type> <context> The 7.50 % senior debentures are not redeemable prior to their maturity. All other notes may be called at the option of the company subject to “make whole” clauses. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The carrying amount of the company’s other short-term borrowings, 3.25 % notes due in 2024, North American asset securitization program, commercial paper, uncommitted lines of credit, and other obligations approximate their fair value. | text | 3.25 | percentItemType | text: <entity> 3.25 </entity> <entity type> percentItemType </entity type> <context> The carrying amount of the company’s other short-term borrowings, 3.25 % notes due in 2024, North American asset securitization program, commercial paper, uncommitted lines of credit, and other obligations approximate their fair value. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. | text | 1.08 | percentItemType | text: <entity> 1.08 </entity> <entity type> percentItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. </context> | us-gaap:DerivativeBasisSpreadOnVariableRate |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. | text | 0.10 | percentItemType | text: <entity> 0.10 </entity> <entity type> percentItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as support for the company’s commercial paper program, as applicable. Interest on borrowings under the revolving credit facility is calculated using a base rate or SOFR, plus a spread ( 1.08 % at December 31, 2023), which is based on the company’s credit ratings, plus a credit spread adjustment of 0.10 % or a weighted-average effective interest rate of 6.42 % at December 31, 2023. The facility fee, which is based on the company’s credit ratings, was 0.175 % of the total borrowing capacity at December 31, 2023. The company had no outstanding borrowings under the revolving credit facility at December 31, 2023 and 2022. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.